September 09, 2024

LBBW Venture Capital GmbH

LBBW Venture Capital GmbH
Go back

Our latest News

discover more
Donation of over 107,000 euros for sick and underprivileged children

Donation of over 107,000 euros for sick and underprivileged children

As part of the 23rd annual global charity run, the “Roche Children’s Walk,” numerous Roche employees throughout Germany participated in a variety of running, sports, and recreational activities. At the Grenzach-Wyhlen, Mannheim, Penzberg, and Ludwigsburg sites, a total of 53,875 euros was raised. With the German Roche companies matching this amount for global aid projects, […]

read more
VectorBuilder and Lir Therapeutics Partner to Advance AAV Capsids Designed for Clinical Success

VectorBuilder and Lir Therapeutics Partner to Advance AAV Capsids Designed for Clinical Success

CHICAGO – August 18, 2026 – VectorBuilder, a global leader in gene delivery technologies, and Lir Therapeutics, a company pushing the boundaries of vector engineering with AI, today announced a strategic collaboration to develop adeno-associated virus (AAV) capsids designed not only for strong biological performance, but also for the manufacturability and scalability required to bring gene […]

read more
PRAME-specific T-cell therapy in an adolescent with metastatic kidney tumor

PRAME-specific T-cell therapy in an adolescent with metastatic kidney tumor

Researchers and physicians at the Hopp Children’s Cancer Center Heidelberg (KiTZ) and other leading cancer centers report an exceptional treatment success in an adolescent with an advanced, therapy-resistant kidney tumor. Using a novel, personalized T-cell therapy, they succeeded in completely pushing back the tumor disease despite multiple metastases. The individual compassionate-use treatment has now been […]

read more

GET IN TOUCH

Stay Updated with bioRN’s Newsletter

Sign up for our newsletter to discover more!
* required

BioRN (BioRN Network e.V. and BioRN Cluster Management GmbH) will use the information you provide on this form to be in touch with you and to provide updates and marketing. Please let us know all the ways you would like to hear from us:

You can update your subscription preferences or unsubscribe at any time. Just follow the unsubscribe or update link in the footer of automated emails you receive from us, or by contacting us at info@biorn.org. We will treat your information with respect. For more information about our privacy practices please visit our website: www.biorn.org. By clicking below, you agree that we may process your information in accordance with these terms.

We use Mailchimp as our marketing platform. By clicking below to subscribe, you acknowledge that your information will be transferred to Mailchimp for processing. Learn more about Mailchimp's privacy practices.

Intuit Mailchimp